Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.78 |
| ▸ | LMNA | P02545 | 9/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 8/20 | 0.64 |
| ▸ | HTT | P42858 | 6/20 | 0.64 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.58 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.58 |
| ▸ | TNF | P01375 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | STAT3 | P40763 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL10912945 | 0.98 | TDP1 (0.75) | TDP1LMNASMN1; SMN2HTTEGLN3 | |
| SCHEMBL180261 | 0.89 | TDP1 (0.72) | TDP1LMNASMN1; SMN2HTTEGLN3 | |
| SCHEMBL6442808 | 0.88 | TDP1 (1.00) | TDP1LMNASMN1; SMN2HTTEGLN3 | |
| Hydrochloric Acid SCHEMBL28203320 | 0.87 | TDP1 (0.70) | TDP1LMNASMN1; SMN2HTTEGLN3 | |
| SCHEMBL327149 | 0.87 | TDP1 (0.70) | TDP1LMNASMN1; SMN2HTTEGLN3 | |
| SCHEMBL6321085 | 0.86 | TDP1 (0.68) | TDP1LMNASMN1; SMN2HTTEGLN3 | |
| SCHEMBL4888041 | 0.86 | TDP1 (0.68) | TDP1LMNASMN1; SMN2HTTEGLN3 | |
| SCHEMBL9853336 | 0.86 | TDP1 (0.68) | TDP1LMNASMN1; SMN2HTTEGLN3 | |
| SCHEMBL9038701 | 0.86 | TDP1 (0.68) | TDP1LMNASMN1; SMN2HTTEGLN3 | |
| SCHEMBL3868979 | 0.86 | TDP1 (0.68) | TDP1LMNASMN1; SMN2HTTEGLN3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116606290-B | Method for efficiently catalyzing and synthesizing fluorine-containing polypeptide condensing agent by adopting green acid binding agent | 浙江大学 | 2024-11-01 | — | — | CN | claimed |
| CN-116606290-A | Method for efficiently catalyzing and synthesizing fluorine-containing polypeptide condensing agent by adopting green acid binding agent | 浙江大学 | 2023-08-18 | — | — | CN | claimed |
| EP-1984968-B1 | IONIC LIQUID ELECTROLYTE | ECOLE POLYTECHNIQUE FED LAUSANNE EPFL (CH) | 2017-04-05 | — | — | EP | claimed |
| EP-1404321-A1 | 1-ALKYL-2-ARYL-BENZIMIDAZOLE DERIVATIVES, THEIR USE FOR PRODUCING MEDICAMENTS AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID DERIVATIVES | Schering Aktiengesellschaft (DE) | 2004-04-07 | — | — | EP | claimed |
| WO-2003004023-A1 | 1-ALKYL-2-ARYL-BENZIMIDAZOLE DERIVATIVES, THEIR USE FOR PRODUCING MEDICAMENTS AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID DERIVATIVES | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-01-16 | — | — | WO | claimed |
| US-20260015339-A1 | CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY | UNIVERSITE GRENOBLE ALPES (FR) | 2026-01-15 | — | — | US | disclosed |
| EP-4655285-A1 | CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY | Université Grenoble Alpes (FR) | 2025-12-03 | — | — | EP | disclosed |
| CN-113424016-B | Method for obtaining information on an organic solderability preservative on a printed circuit board | 德国艾托特克公司 | 2025-04-15 | — | — | CN | disclosed |
| CN-116606290-B | Method for efficiently catalyzing and synthesizing fluorine-containing polypeptide condensing agent by adopting green acid binding agent | 浙江大学 | 2024-11-01 | — | — | CN | disclosed |
| US-20240300951-A1 | Pyrazolopyridinone Compounds | BEIGENE LTD. (KY) | 2024-09-12 | — | — | US | disclosed |
| US-20240270751-A1 | Pyrazolopyridinone Compounds | BEIGENE LTD. (KY) | 2024-08-15 | — | — | US | disclosed |
| WO-2024156819-A1 | CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY | UNIVERSITE GRENOBLE ALPES (FR) | 2024-08-02 | — | — | WO | disclosed |
| EP-0511187-B1 | Process for the preparation of 1H-benzimidazoles | UCB SA (BE) | 1996-11-20 | — | — | EP | disclosed |
| EP-0511187-A1 | Process for the preparation of 1H-benzimidazoles | U C B, S.A. (BE) | 1992-10-28 | — | — | EP | disclosed |
| EP-0428383-A1 | Process for surface treatment of copper and copper alloy | SHIKOKU CHEMICALS CORPORATION (JP) | 1991-05-22 | — | — | EP | disclosed |
| US-5015473-A | Beta-lactamase inhibitors | PFIZER INC. (US) | 1991-05-14 | — | — | US | disclosed |
| US-4826833-A | ANTIBIOTICS | PFIZER INC. (US) | 1989-05-02 | — | — | US | disclosed |
| US-4620871-A | SALTS OF PHTHALAZINES AND BENZIMIDAZOLES | ESZAKMAGYARORSZAGIVEGYIMUVEK (HU) | 1986-11-04 | — | — | US | disclosed |
| US-4460709-A | Process for producing oxygen-containing organic compounds | AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JP) | 1984-07-17 | — | — | US | disclosed |
| US-4151280-A | ANTIALLERGENS | ROUSSEL UCLAF (FR) | 1979-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015339-A1 | CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY | CBR1, CYP4X1, CBR3 | TDP1 2304/4885LMNA 2391/4885SMN1; SMN2 2691/4885 |
| US-20240300951-A1 | Pyrazolopyridinone Compounds | NFATC1, CD4, PBK | TDP1 959/4885LMNA 4345/4885SMN1; SMN2 2823/4885 |
| US-20240270751-A1 | Pyrazolopyridinone Compounds | NFATC1, CD4, PBK | TDP1 959/4885LMNA 4345/4885SMN1; SMN2 2823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.